tradingkey.logo

Embecta Corp

EMBC
View Detailed Chart
10.865USD
+0.395+3.77%
Close 02/06, 16:00ETQuotes delayed by 15 min
635.56MMarket Cap
6.64P/E TTM

Embecta Corp

10.865
+0.395+3.77%
Intraday
1m
30m
1h
D
W
M
D

Today

+3.77%

5 Days

+2.40%

1 Month

-13.08%

6 Months

+10.08%

Year to Date

-8.54%

1 Year

-37.63%

View Detailed Chart

TradingKey Stock Score of Embecta Corp

Currency: USD Updated: 2026-02-06

Key Insights

Embecta Corp's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 52 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 16.67.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Embecta Corp's Score

Industry at a Glance

Industry Ranking
52 / 205
Overall Ranking
150 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Embecta Corp Highlights

StrengthsRisks
Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 1.08B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 38.36%.
Undervalued
The company’s latest PE is 6.64, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 58.75M shares, decreasing 0.01% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 1.22K shares of this stock.

Analyst Rating

Based on 4 analysts
Hold
Current Rating
16.667
Target Price
+59.19%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Embecta Corp News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Embecta Corp Info

Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.
Ticker SymbolEMBC
CompanyEmbecta Corp
CEOKurdikar (Devdatt)
Websitehttps://www.embecta.com/
KeyAI